Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(8%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
8
67%
Ph phase_4
3
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
Withdrawn2
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (27.3%)
N/A8 (72.7%)

Trials by Status

not_yet_recruiting18%
withdrawn217%
completed650%
recruiting18%
unknown217%

Recent Activity

1 active trials
Showing 5 of 12
not_yet_recruitingnot_applicable

Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

NCT06836778
recruitingphase_4

Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC

NCT06594744
completednot_applicable

8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding

NCT02477384
completednot_applicable

Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.

NCT01196481
unknownnot_applicable

Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis

NCT03069339
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06836778Not Applicable

Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

Not Yet Recruiting
NCT06594744Phase 4

Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC

Recruiting
NCT02477384Not Applicable

8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding

Completed
NCT01196481Not Applicable

Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.

Completed
NCT03069339Not Applicable

Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis

Unknown
NCT04254822Not Applicable

HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients

Unknown
NCT02739581Not Applicable

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Withdrawn
NCT03943784

Endoscopic Variceal Ligation in Children

Completed
NCT02294292Not Applicable

Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality

Completed
NCT01659346Not Applicable

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Withdrawn
NCT01291277Phase 4

Time Interval for Endoscopic Variceal Ligation

Completed
NCT02757703Phase 4

Vasoactive Drugs in Real World Practice

Completed

All 12 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
12